Joomyeong Kim

Last updated
Joomyeong Kim
Joomyeong Kim.jpg
Professor Joomyeong Kim
Born
Joomyeong Kim
NationalityAmerican / South Korean
Education LSU Medical Center at New Orleans, LA (Ph. D.)
Seoul National University (M.S., B.S.)
Alma mater LSU Medical Center at New Orleans, LA (Ph. D., 1995)
Scientific career
Fields Genomic imprinting; Epigenetics
Institutions Oak Ridge National Laboratory
Lawrence Livermore National Laboratory
Louisiana State University

Joomyeong Kim is a Russell Thompson, Jr. Family Professor of Biology at Louisiana State University. His research interests include genomic imprinting and epigenetics. Dr. Kim's laboratory is mainly involved in understanding the functions and regulatory mechanisms governing genes subject to genomic imprinting. [1] Having previously characterized an imprinted domain located on proximal mouse chromosome 7/ human chromosome 19q13.4, his laboratory currently focuses on understanding regulatory mechanisms directing the mono-allelic expression of the seven imprinted genes in the cluster: Peg3, Usp29, Zfp264, APeg3 (paternally expressed) and Zim1, Zim2, Zim3 (maternally expressed). [2] [3] [4] [5] [6] [7] [8] As a second project direction, his lab studies the function of the dominant gene in the cluster, Peg3, as a transcriptional regulator. [9] [10] [11] [12] Past projects in the Kim lab have included studying the epigenetic instability of imprinted genes during tumorigenesis, [13] [14] [15] potential roles of AEBP2 as a PRC2 targeting protein and in neural crest cell development, [16] [17] [18] as well as the DNA methylation of mouse and human retrotransposons. [19] [20]

Contents


Education

Selected publications

Related Research Articles

Genomic imprinting is an epigenetic phenomenon that causes genes to be expressed or not, depending on whether they are inherited from the mother or the father. Genes can also be partially imprinted. Partial imprinting occurs when alleles from both parents are differently expressed rather than complete expression and complete suppression of one parent's allele. Forms of genomic imprinting have been demonstrated in fungi, plants and animals. In 2014, there were about 150 imprinted genes known in mice and about half that in humans. As of 2019, 260 imprinted genes have been reported in mice and 228 in humans.

<span class="mw-page-title-main">Epigenetics</span> Study of DNA modifications that do not change its sequence

In biology, epigenetics are stable heritable traits that cannot be explained by changes in DNA sequence, and the study of a type of stable change in cell function that does not involve a change to the DNA sequence. The Greek prefix epi- in epigenetics implies features that are "on top of" or "in addition to" the traditional genetic mechanism of inheritance. Epigenetics usually involves a change that is not erased by cell division, and affects the regulation of gene expression. Such effects on cellular and physiological phenotypic traits may result from environmental factors, or be part of normal development. They can lead to cancer.

<span class="mw-page-title-main">DNA methylation</span> Biological process

DNA methylation is a biological process by which methyl groups are added to the DNA molecule. Methylation can change the activity of a DNA segment without changing the sequence. When located in a gene promoter, DNA methylation typically acts to repress gene transcription. In mammals, DNA methylation is essential for normal development and is associated with a number of key processes including genomic imprinting, X-chromosome inactivation, repression of transposable elements, aging, and carcinogenesis.

In biochemistry, in the biological context of organisms' regulation of gene expression and production of gene products, downregulation is the process by which a cell decreases the production and quantities of its cellular components, such as RNA and proteins, in response to an external stimulus. The complementary process that involves increase in quantities of cellular components is called upregulation.

An insulator is a type of cis-regulatory element known as a long-range regulatory element. Found in multicellular eukaryotes and working over distances from the promoter element of the target gene, an insulator is typically 300 bp to 2000 bp in length. Insulators contain clustered binding sites for sequence specific DNA-binding proteins and mediate intra- and inter-chromosomal interactions.

Histone methylation is a process by which methyl groups are transferred to amino acids of histone proteins that make up nucleosomes, which the DNA double helix wraps around to form chromosomes. Methylation of histones can either increase or decrease transcription of genes, depending on which amino acids in the histones are methylated, and how many methyl groups are attached. Methylation events that weaken chemical attractions between histone tails and DNA increase transcription because they enable the DNA to uncoil from nucleosomes so that transcription factor proteins and RNA polymerase can access the DNA. This process is critical for the regulation of gene expression that allows different cells to express different genes.

<span class="mw-page-title-main">CTCF</span> Transcription factor

Transcriptional repressor CTCF also known as 11-zinc finger protein or CCCTC-binding factor is a transcription factor that in humans is encoded by the CTCF gene. CTCF is involved in many cellular processes, including transcriptional regulation, insulator activity, V(D)J recombination and regulation of chromatin architecture.

<span class="mw-page-title-main">GABRB2</span> Protein-coding gene in the species Homo sapiens

The GABAA beta-2 subunit is a protein that in humans is encoded by the GABRB2 gene. It combines with other subunits to form the ionotropic GABAA receptors. GABA system is the major inhibitory system in the brain, and its dominant GABAA receptor subtype is composed of α1, β2, and γ2 subunits with the stoichiometry of 2:2:1, which accounts for 43% of all GABAA receptors. Alternative splicing of the GABRB2 gene leads at least to four isoforms, viz. β2-long (β2L) and β2-short. Alternatively spliced variants displayed similar but non-identical electrophysiological properties. GABRB2 is subjected to positive selection and known to be both an alternative splicing and a recombination hotspot; it is regulated via epigenetic regulation including imprinting and gene and promoter methylation GABRB2 has been associated with a number of neuropsychiatric disorders, and found to display altered expression in cancer.

<span class="mw-page-title-main">FOXM1</span> Protein-coding gene in humans

Forkhead box protein M1 is a protein that in humans is encoded by the FOXM1 gene. The protein encoded by this gene is a member of the FOX family of transcription factors. Its potential as a target for future cancer treatments led to it being designated the 2010 Molecule of the Year.

<span class="mw-page-title-main">PEG3</span> Protein-coding gene in the species Homo sapiens

Paternally-expressed gene 3 protein is a protein that in humans is encoded by the PEG3 gene. PEG3 is an imprinted gene expressed exclusively from the paternal allele and plays important roles in controlling fetal growth rates and nurturing behaviors as has potential roles in mammalian reproduction. PEG3 is a transcription factor that binds to DNA [11-13] via the sequence motif AGTnnCnnnTGGCT, which it binds to using multiple Kruppel-like factors. It also regulate the expression of Pgm2l1 through the binding of the motif.

<span class="mw-page-title-main">Rex1</span> Known marker of pluripotency, and is usually found in undifferentiated embryonic stem cells

Rex1 (Zfp-42) is a known marker of pluripotency, and is usually found in undifferentiated embryonic stem cells. In addition to being a marker for pluripotency, its regulation is also critical in maintaining a pluripotent state. As the cells begin to differentiate, Rex1 is severely and abruptly downregulated.

<span class="mw-page-title-main">Small nucleolar RNA SNORD113</span>

In molecular biology, Small nucleolar RNA SNORD113 is a small nucleolar RNA molecule which is located in the imprinted human 14q32 locus and may play a role in the evolution and/or mechanism of the epigenetic imprinting process.

mir-127

mir-127 microRNA is a short non-coding RNA molecule with interesting overlapping gene structure. miR-127 functions to regulate the expression levels of genes involved in lung development, placental formation and apoptosis. Aberrant expression of miR-127 has been linked to different cancers.

In molecular biology, MER1 repeat containing imprinted transcript 1, also known as MIMT1 is a long non-coding RNA. It is an imprinted gene, which is paternally expressed. Deletion of this gene is lethal in cattle, causing still births and abortions. It is lethal in 85% of individuals with the deletion, it is thought that incomplete silencing of maternally imprinted alleles allows some individuals with the deletion to survive.

<span class="mw-page-title-main">Cancer epigenetics</span> Field of study in cancer research

Cancer epigenetics is the study of epigenetic modifications to the DNA of cancer cells that do not involve a change in the nucleotide sequence, but instead involve a change in the way the genetic code is expressed. Epigenetic mechanisms are necessary to maintain normal sequences of tissue specific gene expression and are crucial for normal development. They may be just as important, if not even more important, than genetic mutations in a cell's transformation to cancer. The disturbance of epigenetic processes in cancers, can lead to a loss of expression of genes that occurs about 10 times more frequently by transcription silencing than by mutations. As Vogelstein et al. points out, in a colorectal cancer there are usually about 3 to 6 driver mutations and 33 to 66 hitchhiker or passenger mutations. However, in colon tumors compared to adjacent normal-appearing colonic mucosa, there are about 600 to 800 heavily methylated CpG islands in the promoters of genes in the tumors while these CpG islands are not methylated in the adjacent mucosa. Manipulation of epigenetic alterations holds great promise for cancer prevention, detection, and therapy. In different types of cancer, a variety of epigenetic mechanisms can be perturbed, such as the silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications, and dysregulation of DNA binding proteins. There are several medications which have epigenetic impact, that are now used in a number of these diseases.

Behavioral epigenetics is the field of study examining the role of epigenetics in shaping animal and human behavior. It seeks to explain how nurture shapes nature, where nature refers to biological heredity and nurture refers to virtually everything that occurs during the life-span. Behavioral epigenetics attempts to provide a framework for understanding how the expression of genes is influenced by experiences and the environment to produce individual differences in behaviour, cognition, personality, and mental health.

<span class="mw-page-title-main">AEBP2</span> Protein-coding gene in humans

Adipocyte Enhancer-Binding Protein is a zinc finger protein that in humans is encoded by the evolutionarily well-conserved gene AEBP2. It was initially identified due to its binding capability to the promoter of the adipocyte P2 gene, and was therefore named Adipocyte Enhancer Binding Protein 2. AEBP2 is a potential targeting protein for the mammalian Polycomb Repression Complex 2 (PRC2).

Generally, in progression to cancer, hundreds of genes are silenced or activated. Although silencing of some genes in cancers occurs by mutation, a large proportion of carcinogenic gene silencing is a result of altered DNA methylation. DNA methylation causing silencing in cancer typically occurs at multiple CpG sites in the CpG islands that are present in the promoters of protein coding genes.

H3K27me3 is an epigenetic modification to the DNA packaging protein Histone H3. It is a mark that indicates the tri-methylation of lysine 27 on histone H3 protein.

DNA methylation in cancer plays a variety of roles, helping to change the healthy cells by regulation of gene expression to a cancer cells or a diseased cells disease pattern. One of the most widely studied DNA methylation dysregulation is the promoter hypermethylation where the CPGs islands in the promoter regions are methylated contributing or causing genes to be silenced.

References

  1. "Joomyeong Kim" . Retrieved Nov 15, 2017.
  2. Kim J, Ekram MB, Kim H, Faisal M, Frey WD, Huang JM, Tran K, Kim MM, Yu S (2012). "Imprinting control region (ICR) of the Peg3 domain". Hum Mol Genet. 21 (12): 2677–87. doi:10.1093/hmg/dds092. PMC   3363340 . PMID   22394678.
  3. Thiaville MM, Kim H, Frey WD, Kim J (2013). "Identification of an evolutionarily conserved cis-regulatory element controlling the Peg3 imprinted domain". PLOS ONE. 8 (9): e75417. doi: 10.1371/journal.pone.0075417 . PMC   3769284 . PMID   24040411.
  4. Kim J, Ye A (2016). "Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain". PLOS ONE. 11 (4): e0154216. doi: 10.1371/journal.pone.0154216 . PMC   4841594 . PMID   27104590.
  5. Perera BP, Kim J (2016). "Alternative promoters of Peg3 with maternal specificity". Sci Rep. 6: 24438. doi:10.1038/srep24438. PMC   4830991 . PMID   27075691.
  6. He H, Perera BP, Ye A, Kim J (2016). "Parental and sexual conflicts over the Peg3 imprinted domain". Sci Rep. 6: 38136. doi:10.1038/srep38136. PMC   128876 . PMID   27901122.
  7. He H, Ye A, Perera BP, Kim J (2017). "YY1's role in the Peg3 imprinted domain". Sci Rep. 7 (1): 6427. doi:10.1038/s41598-017-06817-5. PMC   5526879 . PMID   28743993.
  8. Bretz CL, Kim J (2017). "Transcription-driven DNA methylation setting on the mouse Peg3 locus". Epigenetics. Sep 19 [Epub ahead of print] (11): 945–952. doi:10.1080/15592294.2017.1377869. PMC   5788428 . PMID   28925797.
  9. Ye A, He H, Kim J (2014). "Paternally expressed Peg3 controls maternally expressed Zim1 as a trans factor". PLOS ONE. 9 (9): e108596. doi: 10.1371/journal.pone.0108596 . PMC   4180786 . PMID   25265264.
  10. Lee S, Ye A, Kim J (2015). "DNA-Binding Motif of the Imprinted Transcription Factor PEG3". PLOS ONE. 10 (12): e0145531. doi: 10.1371/journal.pone.0145531 . PMC   4686966 . PMID   26692216.
  11. Ye A, He H, Kim J (2016). "PEG3 binds to H19-ICR as a transcriptional repressor". Epigenetics. 11 (12): 889–900. doi:10.1080/15592294.2016.1255385. PMC   5193492 . PMID   27824289.
  12. Ye A, He H, Kim J (2017). "PEG3 control on the mammalian MSL complex". PLOS ONE. 12 (6): e0178363. doi: 10.1371/journal.pone.0178363 . PMC   5469463 . PMID   28609438.
  13. Kim J, Bretz CL, Lee S (2015). "Epigenetic instability of imprinted genes in human cancers". Nucleic Acids Res. 43 (22): 10689–99. doi:10.1093/nar/gkv867. PMC   4678850 . PMID   26338779.
  14. Bretz CL, Langohr IM, Lee S, Kim J (2015). "Epigenetic instability at imprinting control regions in a Kras(G12D)-induced T-cell neoplasm". Epigenetics. 10 (12): 1111–201. doi:10.1080/15592294.2015.1110672. PMC   4844204 . PMID   26507119.
  15. Bretz CL, Langohr IM, Kim J (2017). "Epigenetic response of imprinted domains during carcinogenesis". Clin Epigenetics. 9: 90. doi: 10.1186/s13148-017-0393-8 . PMC   5572065 . PMID   28855972.
  16. Kim H, Kang K, Kim J (2009). "AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2". Nucleic Acids Res. 37 (9): 2940–50. doi:10.1093/nar/gkp149. PMC   2685092 . PMID   19293275.
  17. Kim H, Kang K, Ekram MB, Roh TY, Kim J (2011). "Aebp2 as an epigenetic regulator for neural crest cells". PLOS ONE. 6 (9): e25174. doi: 10.1371/journal.pone.0025174 . PMC   3176318 . PMID   21949878.
  18. Kim H, Ekram MB, Bakshi A, Kim J (2015). "AEBP2 as a transcriptional activator and its role in cell migration". Genomics. 105 (2): 108–15. doi:10.1016/j.ygeno.2014.11.007. PMC   4314425 . PMID   25451679.
  19. Bakshi A, Kim J (2014). "Retrotransposon-based profiling of mammalian epigenomes: DNA methylation of IAP LTRs in embryonic stem, somatic and cancer cells". Genomics. 104 (6): 538–44. doi:10.1016/j.ygeno.2014.09.009. PMC   4262695 . PMID   25277721.
  20. Bakshi A, Herke SW, Batzer MA, Kim J (2016). "ADNA methylation variation of human-specific Alu repeats". Epigenetics. 11 (2): 163–73. doi:10.1080/15592294.2015.1130518. PMC   4846114 . PMID   26890526.